The evidence regarding fatty acids and breast cancer risk is inconclusive. Adipose tissue fatty acids can be used as biomarkers of fatty acid intake and of endogenous fatty acid exposure. Fatty acids in adipose tissue are correlated owing to common dietary sources and shared metabolic pathways, which group fatty acids into naturally occurring patterns. We aimed to prospectively investigate associations between adipose tissue fatty acid patterns and long-term risk of total breast cancer and breast cancer subtypes characterised by oestrogen and progesterone receptor status (ER and PR). SUBJECTS/METHODS: This case-cohort study was based on data from the Danish cohort Diet, Cancer and Health. At baseline, a fat biopsy and information on lifestyle and reproductive factors were collected. From the 31 original fatty acids measured, patterns of fatty acids were identified using the treelet transform. During a median follow-up of 5.3 years, 474 breast cancer cases were identified. Hazard ratios and 95% confidence intervals of risk of total breast cancer and of subtypes according to quintiles of factor score were determined by weighted Cox proportional hazards regression. RESULTS: After adjustment for potential confounders, factor scores for the seven patterns identified by the treelet transform were not associated with risk of total breast cancer, nor with risk of ER+, ER − , PR+ or PR − tumours. 
INTRODUCTION
With an annual incidence of 1.4 million new cases, corresponding to 23% of cancer diagnoses in women, breast cancer is the most frequent cancer among women worldwide. 1 Several risk factors for breast cancer have been established, but the aetiology of breast cancer remains largely unknown. 2 Furthermore, subtypes of breast cancer categorised according to oestrogen and progesterone receptor (ER and PR, respectively) status might have different aetiologies. 3 Intake of fatty acids may be related to breast cancer risk, 4 but the intake is difficult to measure accurately with dietary assessment instruments, and may not represent the endogenous exposure of the breast cells. 5 In contrast, the fatty acid composition of adipose tissue and blood lipids reflects dietary intake of some fatty acids over the past month and up to 2 years, but also absorptive and metabolic processes, genetics and lifestyle. 6, 7 Levels of fatty acids in tissue stores may thus more clearly reflect the environment the breast cells are exposed to than estimated dietary intake, 5 and may therefore display stronger associations with disease. 8, 9 Epidemiological studies on the fatty acid composition of tissue stores and risk of breast cancer have yielded inconclusive results. 10 Most studies have investigated individual fatty acids or the traditional classes of fatty acids based on chemical structure such as saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), trans fatty acids and polyunsaturated fatty acids (PUFA). However, many fatty acids originate from the same dietary sources or follow the same elongation and desaturation pathways. Their levels within the adipose tissue are therefore highly correlated, giving rise to naturally occurring patterns in fatty acid composition. 11, 12 Studies of individual fatty acids do not capture these correlations and may overly simplify the complexity of fatty acid composition in the body. Methods describing patterns by taking correlations into account, for example, the treelet transform (TT), 13 could potentially facilitate new insight into the potential associations of fatty acids with breast cancer risk. The purpose of the present study was to prospectively investigate associations between patterns of adipose tissue fatty acids determined by TT and long-term risk of total breast cancer, as well as its subtypes categorised by ER and PR status.
SUBJECTS AND METHODS Subjects
This case-cohort study was based on data from the prospective Danish cohort Diet, Cancer and Health, the Danish branch of the European Prospective Investigation into Cancer and Nutrition.
14 During the period 1993-1997, a total of 57 053 men and women were recruited; they were between 50 and 64 years of age, born in Denmark and free of cancer at the time of enrolment. 15 The participants were followed from the date of their baseline examination until cancer diagnosis, death, emigration or 27 April 2006, whichever occurred first. All participants gave written informed consent, and Diet, Cancer and Health was approved by the ethical committees in Aarhus and Copenhagen.
Information on vital status and emigration was obtained by linking cohort members to the Civil Registration System using the unique civil registration number assigned to all Danish residents. Information on cancer diagnoses was found in three national registries: the Danish Cancer Registry, which holds information on all cancer cases in the Danish population owing to mandatory reporting since 1987, 16 the Pathology Bank and the Danish Breast Cancer Cooperative Group. From this latter registry, information on receptor status was obtained, but information on PR status was not registered systematically. 17 A standardized immunohistologic method was used to detect ER and PR, and receptor status was defined as positive if ⩾ 10% of tumour cells possessed the receptors.
During follow-up, 1074 women were diagnosed with breast cancer 5 ( Figure 1 ). Only women with the two most common types of breast cancer-invasive ductal and lobular carcinoma-were included in the present study corresponding to 95% of breast cancer cases. Fat biopsies from 409 breast cancer cases diagnosed between baseline and 31 December 2000 had been used in an earlier study, 18 leaving no fat for analysis of fatty acids. Thus 1 January 2001 was defined as the start date of follow-up for the present study. All participants who were diagnosed with cancer (breast cancer or other types), had died, or had emigrated before this date were excluded, leaving 29 207 women in the study cohort.
In order to economize the use of fat biopsies, a case-cohort design was used. Accordingly, the study population consisted of all breast cancer cases identified between 1 January 2001 and 27 April 2006, alongside a subcohort of 1215 participants randomly sampled among participants who were still in the cohort after the change in the start of the follow-up.
Breast cancer cases for whom the diagnosis could not be histologically validated were excluded. The validation was done by reviewing pathology reports from the Pathology Bank and comparing this information with information from the other registries. Furthermore, participants with an incomplete fatty acid profile were excluded. Before analysis of breast cancer risk, participants with missing data on one or more of the potential covariates were excluded.
Fatty acid analysis
An adipose tissue biopsy of 35-50 mg subcutaneous fat was taken from the upper, outer part of the buttock at the baseline examination using a luer-lock system (Terumo, Terumo Corporation, Tokyo, Japan), consisting of a needle, a connector (Venoject multisample Luer adaptor) and an evacuated blood tube. 15 The biopsies were stored in the connector in liquid nitrogen at − 150°C until analysis. Studies have shown that longterm storage of fat biopsies only caused minor changes in fatty acids composition. 6, 19 Before analysis, the biopsies were defrosted and 2-4 mg of fat was removed from the connector. The fat was dissolved in heptane and fatty acids were trans-esterified by potassium hydroxide in methanol consistent with standard methods. 20 The composition of fatty acids was analysed by gas chromatography using a Varian 3900 GC with a CP-8400 auto sampler and CP-Sil 88, 60 m × 0.25 mm ID capillary column (Varian, Middelburg, Netherlands) and using helium as carrier gas. Identification of individual fatty acids was performed using commercial standards (Nu-Chek-Prep, Inc., Elysian, MN, USA) that enable quantification of fatty acid methyl esters with 12-24 carbon atoms, and 31 fatty acids were determined ( Table 1 ). The combinations of 18:1 n-6 (Δ12t) and 18:1 n-8 (Δ10t), and 18:1 n-10 (Δ8t) and 18:1 n-12 (Δ6t) were analysed owing to unsuccessful separation of peaks for these fatty acids. 12 The inter-assay coefficients of variation for the fatty acids ranged from 0.7 to 11.7%.
Assessment of covariates
At the baseline examination, participants filled in a self-administered questionnaire on lifestyle, medical history and reproductive factors. The questionnaires were checked for missing information and errors by optical scanning immediately after completion. Any unclear information was corrected during an interview performed by a trained lab technician who also measured weight and height for calculation of body mass index. 15 
Statistical analyses
Baseline characteristics were examined for cases and members of the subcohort separately, and the average percentages of adipose tissue fatty acids in sub-cohort members were examined.
To derive patterns of fatty acids we used the TT. This is a dimensionreduction method, which uses the correlation matrix of multidimensional data like fatty acids to derive patterns, or factors, which are in reality vectors. 13 The numeric size of the original fatty acid in a factor is called the loading. Because analysing the correlation matrix standardizes the fatty acid variables, a positive loading corresponds to a larger-than-average value of the fatty acid; a zero loading corresponds to an average value; and a negative loading corresponds to a smaller-than-average value of the fatty acid. Factors derived by TT are sparse so that not all fatty acids contribute to every factor. Participants are assigned a factor score using the individual-level weights associated with each factor. A high score for a particular factor corresponds to a participant having a fatty acid profile that matches the factor loadings well.
TT was performed according to the method described by GorstRasmussen et al. 13, 21 and based on fatty acids from members of the subcohort (n = 1112). In brief, closely correlated fatty acids were joined into one variable (depicted by a cluster tree; Figure 2 ), which had to be cut to derive factors. Initially, the tree was cut at a range of cut-levels (from 22 to 26) to determine how many factors to retain; namely factors with variance ⩾ 1.25. The optimal cut-level for this number of factors was then determined by use of a 10-fold cross-validation. 13, 21 The TT tree was cut at the optimal level, the factors extracted and participants were assigned factor scores for each factor according to their own fatty acid profiles.
To examine the association between patterns of fatty acids and total breast cancer risk, factor scores were divided into quintiles based on members of the study population sub-cohort. Hazard ratios (HR) and 95% confidence intervals (CI) for each quintile were calculated relative to the first quintile by weighted Cox proportional hazards regression using age as the time axis and robust variance estimates. 23 Cases were assigned weight 1, whereas non-cases were assigned weight N/n; N and n being the number of non-cases in the study cohort and the sub-cohort, respectively. A P-value for trend (P(trend)) was calculated by entering quintiles of factor scores as continuous ordinal variables in the regressions. Two-sided P-values o0.05 were considered statistically significant in all analyses.
An unadjusted and one adjusted regression models were explored. The adjusted model included: body mass index (o 20; 20-o25; 25-o 30; ⩾30 kg/m 2 ), smoking (never; former; current o15; current 15-25; current >25 g tobacco/day), alcohol consumption (g/day, as a continuous variable), hormone replacement therapy (never; former; current), number of childbirths (0; 1; 2; 3; ⩾4), age at first childbirth (years, as a continuous variable), age at menarche (o 12; 12-o14; ⩾14 years; unknown), benign breast tumour surgery (yes; no; unknown), physical activity (⩽3.5; >3.5 h/week) and education (⩽7; 8-10; >10 years). The proportional hazard assumption was visually examined by using plots of log(− log(probability of being free of breast cancer)) and no appreciable violations were found.
The association between patterns of fatty acids and risk of breast cancer subtypes, ER+, ER − , PR+ and PR − , was analysed as described for total breast cancer risk.
TT factor scores can be correlated, potentially leading to confounding. 13 Thus, a sensitivity analysis was performed: the factor-specific adjusted regressions for total breast cancer risk were further adjusted (using quintiles) for all factor scores that had an absolute correlation > 0.2 with the score of the factor under investigation. All analyses were performed in STATA, version 11 (StataCorp LP, College Station, TX, USA).
RESULTS
After exclusion of non-validated cases (n = 23) and participants with incomplete fatty acid profiles (n = 105), the study population consisted of 1570 women (Figure 1 ). Of these, 474 were breast cancer cases, 1112 were members of the sub-cohort and 16 were both. Information on covariates was missing for 57 of these women who were excluded before analyses of breast cancer risk. Thus, these analyses were based on 459 cases and 1070 members of the sub-cohort including 16 cases. The median duration of follow-up was 5 years and 4 months.
The mean age at start of the follow-up was 61 years (Table 2) . Cases were more often current users of hormone replacement therapy, had higher alcohol consumption, had more often had benign breast tumour surgery and had given birth fewer times than members of the sub-cohort. Body mass index, smoking, age at first childbirth and menarche, physical activity and level of education were more equally distributed between the groups.
The most abundant fatty acids in adipose tissue were 18:1 n-9, 16:0 and 18:2 n-6 constituting 44.3% (s.d. 1.9), 19.3% (s.d. 1.9) and 10.9% (s.d. 2.0) of total fatty acids, respectively (Table 1) . TT1  TT2  TT3  TT4  TT5  TT6  TT7 12:0 Lauric acid 0.4 (0. The TT identified seven factors, or patterns, with variances of ⩾ 1.25. These factors explained 66.5% of the total variance, and fatty acid loadings for each factor were positive (Table 1) . Fatty acids joined at the optimal cut-level 22 were grouped in the same pattern and all except 18:1 n-9 and 18:3 n-6 were contained in exactly one pattern (Figure 2 ). TT2 and TT5 were comprised solely of n-3 PUFA and trans fatty acids, respectively. TT1, TT3 and TT4 were dominated by SFA, long-chain MUFA and n-6 PUFA, respectively, whereas MUFA and n-6 PUFA were the main fatty acids in TT6 and TT7, respectively.
No clear associations between patterns of fatty acids and risk of total breast cancer were observed (Table 3) . A slight tendency towards higher risk of breast cancer with higher factor score for TT3, TT4 and TT5 was observed, but no clear dose-response associations were found.
Of the 459 cases in the analysis population, 384 (84%) had ER+ tumours, 59 (13%) had ER − tumours, 162 (35%) had PR+ tumours and 91 (20%) had PR − tumours. ER and PR status was unknown for 16 (3%) and 206 (45%) cases, respectively. Similar to the analysis of total breast cancer risk, no clear associations between patterns of fatty acids and risk of ER+, ER − , PR+ or PR − tumours were found (Table 4) . Only weak tendencies towards a higher risk of ER+ tumours for TT5 and a higher risk of ER − tumours for TT4 and TT7 were observed. In contrast, a slight tendency towards a lower risk of PR+ tumours for TT2 was observed.
In general, the correlations between factor scores were substantial; approximately half of the correlations (11 out of 21) were more extreme than the chosen cutoff at ± 0.2 (data not shown). When these factor scores were simultaneously added in quintiles to the adjusted model for total breast cancer risk, the association for both TT3 and TT4 with risk of breast cancer were strengthened, and both reached statistical significance (HR (95% CI) for TT3 adjusted for TT1, TT4 and TT5 in the 5th quintile was 1.42 (0.91-2.21), P(trend) = 0.04; for TT4 adjusted for TT1-TT3 and TT5 the corresponding numbers were 1.54 (0.92-2.58), P(trend) = 0.03). However, no clear dose-response relationships were found.
DISCUSSION
In the present study, no clear associations between patterns of fatty acids and long-term risk of breast cancer or risk of ER+, ER − , PR+ or PR − tumours were observed. After adjusting for correlated factor Data are n (%) if not specified as median (5th; 95th percentile). b n = 1091 for hormone replacement therapy, 1104 for number of childbirths, 1109 for benign breast surgery and 1110 for education, owing to missing data. c n = 467 for hormone replacement therapy, owing to missing data.
d Only for women who had given birth; cases, n = 394; sub-cohort, n = 967.
scores, positive associations were observed between the risk of breast cancer and TT3 and TT4 (dominated by MUFA and n-6 PUFA, respectively). However, interpretation of the fully adjusted model is complex. Common dietary sources partly explain the correlations and thus it is not possible to change the factor score for one pattern without affecting ones factor score in other patterns. The fatty acids grouped in patterns were only to some extent comparable to the traditional classes of fatty acids based on chemical structure. This could be expected when the correlations between fatty acids induced by dietary sources, metabolic pathways and the complex interplay of product inhibition, genetics and fatty acids competing for enzymes 7 are taken into consideration. The results of this study must be interpreted in light of the potential for bias and confounding. First, selection bias owing to misclassification of breast cancer cases is unlikely to have affected the results, as cases were identified via three national registers, which contain information on all cancer diagnoses in Danish residence, and diagnoses were subsequently validated. However, the lack of information on the fatty acid composition from women developing breast cancer close to baseline is a limitation. This precluded assessment of short-term effects of fatty acid patterns on breast cancer, and it might have resulted in selection bias. 24 Breast cancer occurring shortly after baseline is likely to be in women who are susceptible to a potential effect of fatty acid composition on breast cancer, but these are overlooked in the present analysis. Thus, the study cohort is likely to comprise less susceptible women compared with all women recruited in the original Diet, Cancer and Health cohort.
Second, adipose tissue fatty acids do not possess the weaknesses related to collection of dietary information, such as erroneous reporting, 25 reducing the potential for information bias. Furthermore, the investigation of patterns of fatty acids identified by TT allowed us to investigate the naturally occurring patterns in fatty acid composition and did not limit us to investigation of individual fatty acids, where information on these correlations would be overlooked. However, the patterns identified by TT explain variation of fatty acids in the population, and the biological relevance of mathematically derived patterns may be questioned. 26, 27 Just one measurement of fatty acids composition was available, and as the composition might change over time owing to changes in diet or metabolism, our results may underestimate effect sizes.
Finally, to address confounding, several factors related to breast cancer were included in the multivariate regression models. In addition, a sensitivity analysis further adjusting for correlated fatty acid patterns was conducted. However, residual confounding may still have affected our results.
Studies have indicated that the association between tissue fatty acids and risk of breast cancer might differ by menopausal status. 28, 29 However, owing to the small number of women still premenopausal at the start of follow-up in the study, we were unable to investigate this association stratified by menopausal status.
Only one previous study has investigated the relationship between breast cancer risk and patterns of fatty acids (determined by principal component analysis).
11 This case-control study found a protective effect of a pattern characterised by a low n-6/n-3 PUFA ratio, low levels of 18:2 n-6 and high levels of MUFA. A pattern characterised by low levels SFA and high levels of n-6 PUFA was not associated with risk of breast cancer.
Other studies of fat composition in tissue stores all investigated individual fatty acids or the traditional classes of fatty acids. The majority of cohort studies investigating SFA, 10, [30] [31] [32] [33] 10 Some studies published later have supported this finding, over all 35, 36 or for premenopausal women only, 29 whereas others have not. 5, 30, 33, 37, 38 The discrepancy might be attributed to the proportions of n-3 PUFA in tissue stores. In most studies suggestive of a protective effect, the women had a high proportion of n-3 PUFA, 31, 35, 36 but in studies not documenting an association, the women had low proportions of n-3 PUFA in the tissue. 5, 28, [37] [38] [39] [40] This could indicate a threshold for a protective effect of n-3 PUFA on breast cancer risk. Our findings of no clear ), smoking (never; former; current o15; current 15-25; current >25 g tobacco/day), alcohol consumption (g/day, as a continuous variable), hormone replacement therapy (never; former; current), number of childbirths (0; 1; 2; 3; ⩾ 4), age at first childbirth (years, as a continuous variable), age at menarche (o 12; 12-o 14; ⩾ 14 years; unknown), benign breast tumour surgery (yes; no; unknown), physical activity (⩽3.5; >3.5 h/week) and education (⩽ 7; 8-10; >10 years).
association between TT2 (comprised solely of n-3 PUFA) and risk of breast cancer would be consistent with a threshold effect, as proportions of n-3 PUFA in the present study were low.
In conclusion, no clear associations between the baseline patterns of fatty acids identified by TT and long-term risk of breast cancer or of ER+, ER − , PR+ or PR − tumours were observed. These findings indicate that the dominating patterns of adipose tissue fatty acids, explaining the most variance in the population, do not affect the long-term risk of breast cancer. 2 ), smoking (never; former; current o 15; current 15-25; current >25 g tobacco/day), alcohol consumption (g/day, as a continuous variable), hormone replacement therapy (never; former; current), number of childbirths (0; 1; 2; 3; ⩾ 4), age at first childbirth (years, as a continuous variable), age at menarche (o 12; 12-o14; ⩾ 14 years; unknown), benign breast tumour surgery (yes; no; unknown), physical activity (⩽ 3.5; >3.5 h/week) and education (⩽ 7; 8-10; >10 years).
b Numbers of sub-cohort members: ER, n = 1069; PR, n = 1063.
